DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

NCT04616729 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female

Interventions

DRUG: Triptorelin 3.75 MG Injection
PROCEDURE: Transvaginal oocyte retrieval
DRUG: Triptorelin Injection

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]